JACQUELINE NIGAM: Open Payments
NPI 1265884993 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $66
Food & beverage: $66
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Mirum Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: IQIRVO, Livmarli, LOKELMA.
Industry payments across NY — which companies pay providers there.
